Shoji Oura
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Pathology and Forensic Medicine top 10%
- Molecular Biology
- Co-authors
- Tatsuya YoshimasuYoshitaka OkamuraIssei HiraiYozo KokawaTakeshi TamakiRie NakamuraHirokazu TaninoShinichiro Makimoto
- Topics
- Breast Cancer Treatment Studies (24 papers)Breast Lesions and Carcinomas (20 papers)Cancer Diagnosis and Treatment (19 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer
- Partner nations
- JapanUnited States
In The Last Decade
Shoji Oura
107 papers receiving 747 citations
Peers
Comparison fields: 5 of 83
- Oncology 343
- Pulmonary and Respiratory Medicine 222
- Cancer Research 201
- Pathology and Forensic Medicine 160
- Molecular Biology 141
Countries citing papers authored by Shoji Oura
This map shows the geographic impact of Shoji Oura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoji Oura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoji Oura more than expected).
Fields of papers citing papers by Shoji Oura
This network shows the impact of papers produced by Shoji Oura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoji Oura. The network helps show where Shoji Oura may publish in the future.
Co-authorship network of co-authors of Shoji Oura
This figure shows the co-authorship network connecting the top 25 collaborators of Shoji Oura. A scholar is included among the top collaborators of Shoji Oura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoji Oura. Shoji Oura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 0 | |
| 13 | 10 | |
| 14 | 1 | |
| 15 | 11 | |
| 16 | 9 | |
| 17 | [Breast cancer with osteoblastic bone metastasis treated successfully with bisphosphonate: a case report]. | 1 |
| 18 | Pirarubicin might partly circumvent the P-glycoprotein-mediated drug resistance of human breast cancer tissues. | 8 |
| 19 | Clinical application of histoculture drug response assay (HDRA) - Distribution pattern of inhibition index and predictability of clinical chemo-therapy effects - | 2 |
| 20 | 1 |
About Shoji Oura
Shoji Oura is a scholar working on Oncology, Dermatology and Cancer Research, having authored 140 papers that have together received 761 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (24 papers), Breast Lesions and Carcinomas (20 papers) and Cancer Diagnosis and Treatment (19 papers). The work is most often cited by research in Cancer Research (201 citations), Oncology (343 citations) and Pathology and Forensic Medicine (160 citations). Shoji Oura has collaborated with scholars based in Japan and United States. Frequent co-authors include Tatsuya Yoshimasu, Yoshitaka Okamura, Issei Hirai, Yozo Kokawa, Takeshi Tamaki, Rie Nakamura, Hirokazu Tanino, Shinichiro Makimoto, Mitsumasa Kawago and Takaomi Suzuma. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.